CClinicalTrials.gg
CompletedNCT05024617Updated Aug 27, 2021

Stage-Specific Recovery Changes in the International Classification of Functioning Components Following Conservative Rehabilitation of Trigger Finger

An observational study in Trigger Finger, sponsored by Hacettepe University. Completed at 1 site in Turkey. Open to participants aged 35 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-08-27.

Sponsored by Hacettepe University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
34
Ages
35 Years to 65 Years
Sex
All
01

Study summary

The aim of this study was to determine the effectiveness of conservative rehabilitation on the multi-dimensional health components based on WHO ICF model in Stage 1, Stage 2 and Stage 3 trigger finger and to determine the functional recovery patterns of each dimension during a three-month rehabilitation period. Thirty-four patients were participated in the study.

02

Conditions studied

  • Trigger Finger

Keywords

  • trigger finger
  • ICF
  • rehabilitation
  • splinting
03

In context

Trigger Finger Disorder

94 studies on the registry are indexed under Trigger Finger Disorder; 22 are open to participants now.

This study's enrollment of 34 is below the median of 60 across 13 observational studies indexed under Trigger Finger Disorder.

Browse Trigger Finger Disorder studies →

Lead sponsor

Hacettepe University is the lead sponsor of 983 studies on the registry; 212 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Diagnosed with Stage 1, Stage 2 and Stage 3 trigger finger based on the Froimson Classification

Inclusion criteria

  • Diagnosed with Stage 1, Stage 2 and Stage 3 trigger finger based on the Froimson Classification

Exclusion criteria

Exclusion Criteria:

  • Paediatric trigger finger, trigger thumb, concomitant de'Quervain tenosynovitis, carpal tunnel syndrome, or Dupuytren's contracture, neurological or rheumatological diseases, chronic pain syndromes, pregnancy and patients with treatment history of related finger/fingers.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
34 participants (actual)
Patient registry
No

Groups and cohorts

  • trigger finger stage 1-2-3

    Volunteer patients between 35-65 years old diagnosed with Stage 1, Stage 2 and Stage 3 trigger finger based on the Froimson Classification were included in the study. Exclusion criteria include paediatric trigger finger, trigger thumb, concomitant de'Quervain tenosynovitis, carpal tunnel syndrome, or Dupuytren's contracture, neurological or rheumatological diseases, chronic pain syndromes, pregnancy and patients with treatment history of related finger/fingers

    Other: conservative treatment

Interventions

  • Otherconservative treatment

    All patients had rehabilitation for a total of three months, including activity modification, splinting and exercises.

06

What researchers measure

Primary outcomes

  1. Pain (VAS)

    Time frame: one month

  2. Number of triggering (ten active fist test / 30 second active fist test)

    Time frame: one month

  3. Grip strength (hand dynomometer and pinchmeter)

    Time frame: one month

07

Study locations

1 site
  • Hacettepe University Faculty of Physical Therapy and Rehabilitation
    Ankara, Turkey
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 27, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05024617
Lead sponsor
Hacettepe University
Responsible party
Cigdem Ayhan (Associate Professor (Lecturer), Hacettepe University) — Principal investigator
First posted
Aug 27, 2021
Start date
Mar 2, 2019
Primary completion
May 20, 2019
Completion
Aug 31, 2019
Last update
Aug 27, 2021

Study contacts

Seda Namaldi, MSc
principal investigator · Hacettepe University, Faculty of Physical Therapy and Rehabilitation

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion